节点文献

3D打印非共面模板辅助CT引导125I放射粒子植入治疗脊柱转移瘤的临床应用

CT-guided 125I seed implantation assisted by 3D printing non-coplanar templates in the treatment of spinal metastatic tumors:A clinical application

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 黄海王亮杜振广李福生李光帅张晶周志成徐绍年

【Author】 HUANG Hai;WANG Liang;DU Zhenguang;LI Fusheng;LI Guangshuai;ZHANG Jing;ZHOU Zhicheng;XU Shaonian;Department of Orthopedic Oncology, the People′s Hospital of Liaoning Province;

【通讯作者】 徐绍年;

【机构】 辽宁省人民医院骨与软组织肿瘤科

【摘要】 目的探讨3D打印非共面模板辅助CT引导125I放射粒子植入治疗脊柱转移瘤的临床疗效。方法回顾性分析2017年3月至2019年3月于辽宁省人民医院接受3D打印非共面模板辅助CT引导125I放射粒子植入治疗的脊柱转移瘤患者,评估90%靶区所接受的剂量(D90)、100%处方剂量的体积百分比(V100)、150%处方剂量体积百分比(V150)等参数,评价粒子植入质量,并观察术后并发症及生存情况。结果 15例患者均成功进行了3D打印非共面模板辅助CT引导行125I放射粒子植入,平均放射粒子活度为(0.68±0.10)mCi,平均D90为(12 195.60±1 654.78) cGy,平均V100为(91.69±2.25)%,平均V150为(61.75±11.67)%。术后6个月,疾病控制率为100.00%,客观缓解率为73.33%。中位局部无进展生存时间为17.00个月(95%CI:13.42~20.58个月),中位总生存时间为17.00个月(95%CI:13.42~20.58个月)。术后6个月NRS评分低于术前[(2.27±1.28)分vs(5.00±1.51)分),P<0.001],而KPS评分高于术前[(86.00±12.42)分和(72.67±11.00)分,P<0.001]。术前至术后6个月,ASIA分级C级变为D级,C级变为E级,D级变为E级各1例。结论 3D打印非共面模板辅助CT引导125I放射粒子植入治疗脊柱转移瘤能有效控制局部病灶,明显缓解疼痛及部分神经损伤,且并发症少见,是一种安全、有效的微创姑息性治疗手段。

【Abstract】 Objective To investigate the clinical efficacy of CT-guided 125I seed implantation assisted by three-dimensional printing non-coplanar templates in the treatment of spinal metastatic tumors. Methods A retrospective analysis was performed on patients who underwent CT-guided125I seed implantation assisted by three-dimensional printing non-coplanar templates in the People′s Hospital of Liaoning Province for the treatment of spinal metastatic tumor from March 2017 to March 2019. Parameters such as the dose received at 90% target area(D90), the volume percentage of 100.00% prescription dose(V100) and the volume percentage of 150% prescription dose(V150) were evaluated for seed implantation quality, and postoperative complications and survival were also observed. Results All the 15 patients were successfully implanted125 I seed implantation under CT guidance assisted by three-dimensional printing noncoplanar templates. The average activity of radioactive particles was(0.68 ±0.10) mCi, the average D90(12 195.60±1 654.78) cGy, the average V100(91.69±2.25) %, and the average V150(61.75 ±11.67) %. Six months after the operation, the disease control rate was100%, and the objective remission rate was 73.33%. The median local progression-free survival time was 17.00 months(95% CI:13.42-20.58 months), and the median total survival time 17.00 months(95% CI: 13.42-20.58 months).6 months after operation, NRS score was lower than preoperative[(2.27±1.28) points vs(5.00±1.51) points, P<0.001], while KPS score was higher than preoperative[(86.00±12.42) points and(72.67±11.00) points, P<0.001]. From preoperation to 6 months after operation, ASIA grade was changed from grade C to grade D, from grade C to Grade E, and from grade D to Grade E in each case. Conclusions CT guided125I seed implantation assisted by three-dimensional printing non-coplanar template in the treatment of spinal metastatic tumor can effectively control local lesions, significantly alleviate pain and partial relief of nerve injury, and complications are rare. It is a safe and effective minimally invasive palliative treatment.

【基金】 辽宁省自然科学基金项目(20180530008;20170540518)
  • 【文献出处】 中国癌症防治杂志 ,Chinese Journal of Oncology Prevention and Treatment , 编辑部邮箱 ,2020年06期
  • 【分类号】R738.1;R730.44
  • 【被引频次】2
  • 【下载频次】79
节点文献中: 

本文链接的文献网络图示:

本文的引文网络